Skip to main content

 Scientific publications

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

Authors : Chan DL, Hayes AR, Karfis I, Conner A, Furtado OMahony L, Mileva M, Bernard E, Roach P, Marin G, Pavlakis N, Schembri G, Gnanasegaran G, Marin C, Vanderlinden B, Navalkissoor S, Caplin ME, Flamen P, Toumpanakis C, Bailey DL
Year : 2022
Journal : Br J Cancer
Volume : 128
Pages : 549-55

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.

Authors : Manta R, Delbart W, Duran Derijckere I, Quiriny M, Demetter P, Flamen P, Karfis I
Year : 2022
Journal : Eur J Hybrid Imaging
Volume : 6
Pages : 8

(68)Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.

Authors : Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Year : 2022
Journal : J Nucl Med
Volume : 63
Pages : 1191-1198

Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option.

Authors : Mileva M, Wimana Z, Flamen P, Karfis I
Year : 2021
Journal : World J Nucl Med
Volume : 20
Pages : 316-318

131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paraganglioma.

Authors : Jungels C, Karfis I
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 33-39

Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell lines.

Authors : Delbart W, Ghanem G, Karfis I, Flamen P, Wimana Z
Year : 2021
Journal : Nucl Med Biol
Volume : 96-97
Pages : 68-79

Targeted radionuclide therapy: an emerging field in solid tumours.

Authors : Artigas C, Mileva M, Flamen P, Karfis I
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 493-499

Mantle cell lymphoma simulating inflammatory bowel disease.

Authors : Lifrange F, de Wind R, Spilleboudt C, Karfis I, Van Gossum A, Demetter P
Year : 2021
Journal : Acta Gastroenterol Belg
Volume : 84
Pages : 125-127

Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular Fasciitis.

Authors : Plouznikoff N, Artigas C, Karfis I, Flamen P
Year : 2020
Journal : Clin Nucl Med
Volume : 45
Pages : e41-e42

Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.

Authors : Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P
Year : 2020
Journal : Oncotarget
Volume : 11
Pages : 589-599

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method.

Authors : Cuyle PJ, Geboes K, Carton S, Casneuf V, Decaestecker J, De Man M, Demolin G, Deroose CM, De Vleeschouwer C, Flamen P, Hendlisz A, Hoorens A, Janssens J, Karfis I, Lybaert W, Machiels G, Monsaert E, Sinapi I, van Cutsem E, Vandamme T, Borbath I, Verslype C
Year : 2020
Journal : Acta Gastroenterol Belg
Volume : 83
Pages : 643-653

How COVID-19 pandemic affected cancer progression: Three different scenarios evidenced by PET imaging.

Authors : Mileva M, Artigas C, Gebhart G, Flamen P, Karfis I
Year : 2020
Journal : Hell J Nucl Med
Volume : 23
Pages : 349-353

A dosimetry procedure for organs-at-risk in <sup>177</sup>Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.

Authors : Marin G, Vanderlinden B, Karfis I, Guiot T, Wimana Z, Reynaert N, Vandenberghe S, Flamen P
Year : 2018
Journal : Phys Med
Volume : 56
Pages : 41-49

Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse Event.

Authors : Karfis I, Marin G, Machiels G, Hendlisz A, Flamen P
Year : 2018
Journal : Clin Nucl Med
Volume : 43(7)
Pages : e232-e233

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy.

Authors : Marin G, Vanderlinden B, Karfis I, Guiot T, Wimana Z, Flamen P, Vandenberghe S
Year : 2017
Journal : EJNMMI Phys
Volume : 4
Pages : 7

Unusual diffuse liver 18F-FDG uptake in melanoma patient treated by ipilimumab.

Authors : Muteganya R, Karfis I, Artigas C, Garcia C, Feoli F, Joseph K, Flamen P
Year : 2017
Journal : Hell J Nucl Med
Volume : 20(2)
Pages : 179-181